Starling Oncology, Inc. SEC filings STLN
Starling Oncology, Inc. has 544 filings in SEC EDGAR's recent list, going back to Jan 14, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 2, 2026 | Sep 1, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Aug 21, 2026 | Aug 20, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Aug 3, 2026 | Jul 28, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Jul 7, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2026 | Jun 17, 2026 |
| 8-K | Current report | May 22, 2026 | May 20, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 17, 2026 |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2026 | Mar 13, 2026 |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 23, 2026 | Feb 23, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 7, 2026 | Jan 2, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 1, 2025 | Nov 26, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 14, 2025 | Nov 14, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 6, 2025 | Nov 3, 2025 |
| 424B5 | Prospectus supplement | Aug 13, 2025 | — |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 13, 2025 | Aug 8, 2025 |
| EFFECT | Filing | Jun 18, 2025 | — |
| CORRESP | Letter to the SEC | Jun 16, 2025 | — |
| S-3/A | Form s-3 amendment no. 1 | Jun 16, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2025 | — |
| S-3 | Shelf registration | Jun 6, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 19, 2025 | May 19, 2025 |
| EFFECT | Filing | May 16, 2025 | — |
| CORRESP | Letter to the SEC | May 14, 2025 | — |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| UPLOAD | Letter from the SEC | May 14, 2025 | — |
| S-3 | Shelf registration | May 8, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
May 8, 2025 | May 7, 2025 |
| 8-K |
Current report
Officer or director change
|
May 7, 2025 | May 2, 2025 |
| 8-K |
Current report
Other events
|
Apr 11, 2025 | Apr 9, 2025 |
| D | Filing | Apr 8, 2025 | — |
| DEFA14A | Additional proxy material | Mar 27, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 27, 2025 | Mar 26, 2025 |
| DEF 14A | Proxy statement | Mar 27, 2025 | May 7, 2025 |
| ARS | Annual report to shareholders | Mar 26, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 26, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 25, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 24, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2025 | Mar 24, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 14, 2025 | May 7, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 26, 2025 | Feb 26, 2025 |
| 8-K |
Current report
Listing notice
|
Dec 19, 2024 | Dec 19, 2024 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 12, 2024 | Nov 8, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 23, 2024 | Sep 19, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Listing notice
|
Jun 21, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2024 | Jun 13, 2024 |
| UPLOAD | Letter from the SEC | Jun 3, 2024 | — |
| CORRESP | Letter to the SEC | May 22, 2024 | — |
| 10-Q/A | Amended quarterly report | May 22, 2024 | Mar 31, 2024 |
| 10-K/A | Amended annual report | May 22, 2024 | Dec 31, 2023 |
| UPLOAD | Letter from the SEC | May 15, 2024 | — |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| DEFA14A | Additional proxy material | May 2, 2024 | — |
| DEF 14A | Proxy statement | May 2, 2024 | Jun 13, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 22, 2024 | Jun 13, 2024 |
| 10-K/A | Amended annual report | Apr 22, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 3, 2024 | Apr 3, 2024 |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2024 | Mar 27, 2024 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Other events
|
Sep 18, 2023 | Sep 15, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 6, 2023 | Sep 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 1, 2023 | Sep 1, 2023 |
| 8-K |
Current report
Other events
|
Aug 30, 2023 | Aug 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 10, 2023 | Aug 10, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Other events
|
Jun 15, 2023 | Jun 14, 2023 |
| DEFA14A | Additional proxy material | Jun 14, 2023 | — |
| 8-K/A |
Amended current report
Officer or director change, Regulation FD disclosure
|
Jun 14, 2023 | Jun 8, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 12, 2023 | Jun 11, 2023 |
| 8-K |
Current report
Officer or director change
|
May 22, 2023 | May 18, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Listing notice
|
Apr 27, 2023 | Apr 25, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 27, 2023 | Mar 27, 2023 |
| 8-K/A |
Amended current report
Results of operations
|
Mar 17, 2023 | Mar 9, 2023 |
| 10-K | Annual report | Mar 16, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2023 | Mar 9, 2023 |
| 424B3 | Prospectus | Feb 10, 2023 | — |
| 424B3 | Prospectus | Feb 10, 2023 | — |
| EFFECT | Filing | Feb 9, 2023 | — |
| EFFECT | Filing | Feb 9, 2023 | — |
| POS AM | Filing | Jan 30, 2023 | — |
| POS AM | Filing | Jan 30, 2023 | — |
| 424B3 | Prospectus | Jan 9, 2023 | — |
| EFFECT | Filing | Jan 6, 2023 | — |
| POS AM | Filing | Dec 30, 2022 | — |
| 424B3 | Prospectus | Dec 1, 2022 | — |
| 424B3 | Prospectus | Dec 1, 2022 | — |
| 424B3 | Prospectus | Dec 1, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Dec 1, 2022 | Nov 27, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 15, 2022 | Nov 15, 2022 |
| 424B3 | Prospectus | Nov 10, 2022 | — |
| 424B3 | Prospectus | Nov 10, 2022 | — |
| 424B3 | Prospectus | Nov 10, 2022 | — |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| EFFECT | Filing | Sep 26, 2022 | — |
| 424B3 | Prospectus | Sep 26, 2022 | — |
| S-1/A | Amended registration statement | Sep 23, 2022 | — |
| 424B3 | Prospectus | Sep 22, 2022 | — |
| 424B3 | Prospectus | Sep 22, 2022 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 22, 2022 | Sep 21, 2022 |
| S-1 | Registration statement | Sep 8, 2022 | — |
| D | Filing | Aug 24, 2022 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 16, 2022 | Aug 16, 2022 |
| 424B3 | Prospectus | Aug 10, 2022 | — |
| 424B3 | Prospectus | Aug 10, 2022 | — |
| 424B3 | Prospectus | Aug 10, 2022 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Aug 10, 2022 | Aug 9, 2022 |
| 424B3 | Prospectus | Aug 10, 2022 | — |
| 424B3 | Prospectus | Aug 10, 2022 | — |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jul 15, 2022 | Jul 14, 2022 |
| EFFECT | Filing | Jun 3, 2022 | — |
| 424B3 | Prospectus | Jun 3, 2022 | — |
| DEFA14A | Additional proxy material | Jun 3, 2022 | — |
| DEF 14A | Proxy statement | Jun 3, 2022 | Jul 14, 2022 |
| S-1 | Registration statement | May 19, 2022 | — |
| 424B3 | Prospectus | May 12, 2022 | — |
| 8-K |
Current report
Other events
|
May 12, 2022 | May 12, 2022 |
| S-8 | Employee stock plan registration | May 12, 2022 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 11, 2022 | May 11, 2022 |
| 424B3 | Prospectus | May 11, 2022 | — |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 424B3 | Prospectus | May 9, 2022 | — |
| 424B3 | Prospectus | May 6, 2022 | — |
| 8-K |
Current report
Officer or director change
|
May 5, 2022 | Apr 29, 2022 |
| EFFECT | Filing | May 3, 2022 | — |
| POS AM | Form s-1 | Apr 29, 2022 | — |
| 424B3 | Prospectus | Apr 4, 2022 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 4, 2022 | Apr 1, 2022 |
| 8-K/A | Amended current report | Mar 18, 2022 | Mar 11, 2022 |
| 424B3 | Prospectus | Mar 11, 2022 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 11, 2022 | Mar 11, 2022 |
| 10-K | Annual report | Mar 11, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 10, 2022 | Mar 10, 2022 |
| 424B3 | Prospectus | Mar 8, 2022 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 7, 2022 | Mar 2, 2022 |
| S-8 | Employee stock plan registration | Feb 22, 2022 | — |
| 424B5 | Prospectus supplement | Feb 14, 2022 | — |
| EFFECT | Filing | Feb 11, 2022 | — |
| CORRESP | Letter to the SEC | Feb 9, 2022 | — |
| S-1/A | Amended registration statement | Feb 9, 2022 | — |
| CORRESP | Letter to the SEC | Jan 4, 2022 | — |
| CORRESP | Letter to the SEC | Jan 3, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 21, 2021 | — |
| S-1 | Registration statement | Dec 17, 2021 | — |
| 10-Q/A | Amended quarterly report | Dec 14, 2021 | Sep 30, 2021 |
| 10-K/A | Amended annual report | Dec 14, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Restatement
|
Dec 9, 2021 | Dec 8, 2021 |
| 8-K/A |
Amended current report
Material agreement, Acquisition or sale of assets
|
Nov 22, 2021 | Nov 12, 2021 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
|
Nov 18, 2021 | Nov 12, 2021 |
| 25-NSE | Delisting notice | Nov 12, 2021 | — |
| 10-Q | Quarterly report | Nov 8, 2021 | Sep 30, 2021 |
| EFFECT | Filing | Oct 22, 2021 | — |
| 425 | Filing | Oct 22, 2021 | — |
| 8-K |
Current report
Other events
|
Oct 22, 2021 | Oct 22, 2021 |
| 424B3 | Prospectus | Oct 22, 2021 | — |
| CORRESP | Letter to the SEC | Oct 21, 2021 | — |
| CORRESP | Letter to the SEC | Oct 20, 2021 | — |
| S-4/A | Filing | Oct 20, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 18, 2021 | — |
| 425 | Filing | Oct 12, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 12, 2021 | Oct 12, 2021 |
| S-4/A | Filing | Oct 4, 2021 | — |
| CORRESP | Letter to the SEC | Oct 1, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 24, 2021 | — |
| S-4/A | Filing | Sep 7, 2021 | — |
| CORRESP | Letter to the SEC | Sep 3, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 30, 2021 | — |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| S-4 | Registration for a merger or exchange | Jul 23, 2021 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 29, 2021 | Jun 28, 2021 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
- Listed as
- STLN (Nasdaq), DFPH (OTC), STLNW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cerritos, CA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1799191
- Former names
- Oncology Institute, Inc. (until Aug 3, 2026); DFP HEALTHCARE ACQUISITIONS CORP. (until Nov 12, 2021)
Other Services-Offices & Clinics of Doctors of Medicine companies
- Hims & Hers Health, Inc. HIMS
- Teladoc Health, Inc. TDOC
- SBC Medical Group Holdings Inc SBC
- Auna S.A. AUNA
- Airsculpt Technologies, Inc. AIRS
- LifeMD, Inc. LFMD
- Westin Acquisition Corp WSTN
- Basel Medical Group Ltd BMGL
All 12 Services-Offices & Clinics of Doctors of Medicine companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.